Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
|
|
ARRAY BIOPHARMA INC (ARRY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/30/2019 |
4
| VAN LUNSEN GIL J (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 24,297 shares
@ $48, valued at
$1.2M
Disposed/sold 5,000 shares
@ $0
Disposed/sold 25,000 options to buy
@ $10.47, valued at
$261.8k
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 07/30/2019 |
4
| Squarer Ron (CEO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 259,891 shares
@ $48, valued at
$12.5M
Disposed/sold 442,190 shares
@ $0
Disposed/sold 545,820 options to buy
@ $3.61, valued at
$2M
Disposed/sold 345,312 options to buy
@ $4.63, valued at
$1.6M
Disposed/sold 113,438 options to buy
@ $7.3, valued at
$828.1k
Disposed/sold 453,750 options to buy
@ $3, valued at
$1.4M
Disposed/sold 421,875 options to buy
@ $8.79, valued at
$3.7M
Disposed/sold 600,000 options to buy
@ $10.92, valued at
$6.6M
Disposed/sold 678,750 options to buy
@ $15.97, valued at
$10.8M
|
|
| 07/30/2019 |
4
| Sharp Shalini (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 5,000 shares
@ $48, valued at
$240k
Disposed/sold 5,000 shares
@ $0
Disposed/sold 25,000 options to buy
@ $8.7, valued at
$217.5k
Disposed/sold 25,000 options to buy
@ $10.47, valued at
$261.8k
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 07/30/2019 |
4
| Sandor Victor (Chief Medical Officer) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 209,543 shares
@ $48, valued at
$10.1M
Disposed/sold 114,821 shares
@ $0
Disposed/sold 87,500 options to buy
@ $7.3, valued at
$638.8k
Disposed/sold 187,500 options to buy
@ $3, valued at
$562.5k
Disposed/sold 270,828 options to buy
@ $8.79, valued at
$2.4M
Disposed/sold 289,500 options to buy
@ $10.92, valued at
$3.2M
Disposed/sold 289,500 options to buy
@ $15.97, valued at
$4.6M
|
|
| 07/30/2019 |
4
| Saccomano Nicholas A (CSO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 150,190 shares
@ $48, valued at
$7.2M
Disposed/sold 61,813 shares
@ $0
Disposed/sold 165,000 options to buy
@ $7.3, valued at
$1.2M
Disposed/sold 82,500 options to buy
@ $3, valued at
$247.5k
Disposed/sold 131,250 options to buy
@ $8.79, valued at
$1.2M
Disposed/sold 168,000 options to buy
@ $10.92, valued at
$1.8M
Disposed/sold 138,000 options to buy
@ $15.97, valued at
$2.2M
|
|
| 07/30/2019 |
4
| Robbins Andrew R (COO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 71,022 shares
@ $48, valued at
$3.4M
Disposed/sold 130,542 shares
@ $0
Disposed/sold 12,500 options to buy
@ $8.2, valued at
$102.5k
Disposed/sold 236,250 options to buy
@ $7.3, valued at
$1.7M
Disposed/sold 236,250 options to buy
@ $3, valued at
$708.8k
Disposed/sold 313,989 options to buy
@ $8.79, valued at
$2.8M
Disposed/sold 335,250 options to buy
@ $10.92, valued at
$3.7M
Disposed/sold 315,750 options to buy
@ $15.97, valued at
$5M
|
|
| 07/30/2019 |
4
| Orwin John A (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 15,000 shares
@ $48, valued at
$720k
Disposed/sold 5,000 shares
@ $0
Disposed/sold 20,000 options to buy
@ $4.51, valued at
$90.2k
Disposed/sold 25,000 options to buy
@ $5.6, valued at
$140k
Disposed/sold 25,000 options to buy
@ $3.87, valued at
$96.8k
Disposed/sold 25,000 options to buy
@ $5.13, valued at
$128.3k
Disposed/sold 25,000 options to buy
@ $5.95, valued at
$148.8k
Disposed/sold 25,000 options to buy
@ $10.47, valued at
$261.8k
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 07/30/2019 |
4
| LEFKOFF KYLE (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Unknown transaction of 22,635 shares
@ $48, valued at
$1.1M
Disposed/sold 85 shares
@ $48, valued at
$4.1k
Disposed/sold 5,000 shares
@ $0
Unknown transaction of 20,000 shares
@ $48, valued at
$960k
Unknown transaction of 15,000 shares
@ $48, valued at
$720k
Disposed/sold 30,000 shares
@ $48, valued at
$1.4M
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 07/30/2019 |
4
| Haddock Jason (CFO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 30,059 shares
@ $48, valued at
$1.4M
Disposed/sold 56,026 shares
@ $0
Disposed/sold 404,450 options to buy
@ $3.77, valued at
$1.5M
Disposed/sold 105,302 options to buy
@ $8.79, valued at
$925.6k
Disposed/sold 168,000 options to buy
@ $10.92, valued at
$1.8M
Disposed/sold 157,500 options to buy
@ $15.97, valued at
$2.5M
|
|
| 07/30/2019 |
4
| Fyfe Gwen A. (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 15,000 shares
@ $48, valued at
$720k
Disposed/sold 5,000 shares
@ $0
Disposed/sold 20,000 options to buy
@ $2.6, valued at
$52k
Disposed/sold 20,000 options to buy
@ $4.36, valued at
$87.2k
Disposed/sold 25,000 options to buy
@ $5.6, valued at
$140k
Disposed/sold 25,000 options to buy
@ $3.87, valued at
$96.8k
Disposed/sold 25,000 options to buy
@ $5.13, valued at
$128.3k
Disposed/sold 25,000 options to buy
@ $5.95, valued at
$148.8k
Disposed/sold 25,000 options to buy
@ $10.47, valued at
$261.8k
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 07/30/2019 |
4
| COX CARRIE SMITH (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Disposed/sold 8,000 shares
@ $48, valued at
$384k
Disposed/sold 10,000 shares
@ $0
Disposed/sold 25,000 options to buy
@ $14.93, valued at
$373.3k
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 07/30/2019 |
4
| BAUM CHARLES M (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Unknown transaction of 15,000 shares
@ $48, valued at
$720k
Disposed/sold 5,000 shares
@ $0
Disposed/sold 25,000 options to buy
@ $10.47, valued at
$261.8k
Disposed/sold 25,000 options to buy
@ $14.55, valued at
$363.8k
|
|
| 06/06/2019 |
4
| Sandor Victor (Chief Medical Officer) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 100,000 shares
@ $28.51, valued at
$2.9M
Exercised 100,000 options to buy
@ $7.3, valued at
$730k
|
|
| 06/03/2019 |
4
| Sandor Victor (Chief Medical Officer) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 15,728 shares
@ $27.5, valued at
$432.5k
Sold 36,134 shares
@ $27.5845, valued at
$996.7k
Exercised 15,728 options to buy
@ $3.65, valued at
$57.4k
Exercised 36,134 options to buy
@ $3.65, valued at
$131.9k
|
|
| 05/28/2019 |
4
| Sandor Victor (Chief Medical Officer) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 40,634 shares
@ $26.5011, valued at
$1.1M
Sold 74,915 shares
@ $27.003, valued at
$2M
Exercised 40,634 options to buy
@ $3.65, valued at
$148.3k
Exercised 46,766 options to buy
@ $3.65, valued at
$170.7k
|
|
| 05/23/2019 |
4
| Sandor Victor (Chief Medical Officer) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 12,600 shares
@ $26.5, valued at
$333.9k
Exercised 12,600 options to buy
@ $3.65, valued at
$46k
|
|
| 04/03/2019 |
4
| Robbins Andrew R (COO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 8,660 shares
@ $24.6, valued at
$213k
Exercised 9,844 restricted stock units
@ $0 |
|
| 04/03/2019 |
4
| Squarer Ron (CEO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 16,631 shares
@ $24.6, valued at
$409.1k
Exercised 18,907 restricted stock units
@ $0
Exercised 18,906 restricted stock units
@ $0 |
|
| 04/03/2019 |
4
| Saccomano Nicholas A (CSO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 6,048 shares
@ $24.6, valued at
$148.8k
Exercised 6,875 restricted stock units
@ $0 |
|
| 04/03/2019 |
4
| Sandor Victor (Chief Medical Officer) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 6,932 shares
@ $24.6, valued at
$170.5k
Exercised 7,813 restricted stock units
@ $0 |
|
| 02/21/2019 |
4
| COX CARRIE SMITH (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Bought 5,000 shares
@ $23.1996, valued at
$116k
|
|
| 02/08/2019 |
4
| LEFKOFF KYLE (Director) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 25,000 shares
@ $20.5077, valued at
$512.7k
Sold 5,000 shares
@ $20.8241, valued at
$104.1k
Sold 5,000 shares
@ $20.8522, valued at
$104.3k
Exercised 25,000 options to buy
@ $10.47, valued at
$261.8k
|
|
| 02/08/2019 |
4
| Robbins Andrew R (COO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 239,626 shares
@ $20.025, valued at
$4.8M
Exercised 37,500 options to buy
@ $8.2, valued at
$307.5k
Exercised 87,500 options to buy
@ $4.63, valued at
$405.1k
|
|
| 02/08/2019 |
4
| Haddock Jason (CFO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 11,712 shares
@ $20, valued at
$234.2k
Sold 85,000 shares
@ $22.0506, valued at
$1.9M
Exercised 85,000 options to buy
@ $3.77, valued at
$320.5k
|
|
| 02/08/2019 |
4
| Saccomano Nicholas A (CSO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 187,264 shares
@ $21.5832, valued at
$4M
Exercised 104,764 options to buy
@ $4.2, valued at
$440k
Exercised 82,500 options to buy
@ $3, valued at
$247.5k
|
|
| 02/08/2019 |
4
| Squarer Ron (CEO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 110,000 shares
@ $21.6365, valued at
$2.4M
Exercised 110,000 options to buy
@ $3.61, valued at
$397.1k
|
|
| 02/07/2019 |
4
| Oltmans Curtis Gale (General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Exercised 11,100 shares
@ $8.94, valued at
$99.2k
Sold 40,000 shares
@ $20, valued at
$800k
Exercised 40,000 options to buy
@ $8.94, valued at
$357.6k
|
|
| 02/04/2019 |
4
| Saccomano Nicholas A (CSO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 21,425 shares
@ $18.67, valued at
$400k
Exercised 95,236 options to buy
@ $4.2, valued at
$400k
|
|
| 02/01/2019 |
4
| Squarer Ron (CEO) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 100,000 shares
@ $18.2537, valued at
$1.8M
Sold 113,438 shares
@ $18.5259, valued at
$2.1M
Exercised 100,000 options to buy
@ $3.61, valued at
$361k
Exercised 113,438 options to buy
@ $7.3, valued at
$828.1k
|
|
| 01/29/2019 |
4
| Oltmans Curtis Gale (General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 14,029 shares
@ $18.0001, valued at
$252.5k
Exercised 14,029 options to buy
@ $8.94, valued at
$125.4k
Exercised 11,100 options to buy
@ $8.94, valued at
$99.2k
|
|
| 01/23/2019 |
4
| Oltmans Curtis Gale (General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 1,251 shares
@ $18, valued at
$22.5k
Exercised 1,251 options to buy
@ $8.94, valued at
$11.2k
|
|
| 01/17/2019 |
4
| Oltmans Curtis Gale (General Counsel) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 19,720 shares
@ $18.0598, valued at
$356.1k
Exercised 19,720 options to buy
@ $8.94, valued at
$176.3k
|
|
| 01/02/2019 |
4
| Sandor Victor (Chief Medical Officer) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Sold 6,268 shares
@ $14.0541, valued at
$88.1k
|
|
| 12/18/2018 |
4
| Sandor Victor (Chief Medical Officer) has filed a Form 4 on ARRAY BIOPHARMA INC|
Txns:
| Paid exercise price by delivering 10,378 shares
@ $15.97, valued at
$165.7k
Granted 48,250 restricted stock units
@ $0
Granted 289,500 options to buy
@ $15.97, valued at
$4.6M
Exercised 11,284 restricted stock units
@ $0
Exercised 12,062 restricted stock units
@ $0 |
|
|
|
|